Finance

Beta
Lists
DC4:FRA
DexCom Inc
€61.80
-0.64%
(-0.40) 1D
Jun 5, 8:10:02 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DC4...
Open
€61.80
High
€61.80
Low
€61.80
Mkt. cap
28.01B
Avg. vol.
46.00
Volume
0.00
52-wk high
€77.17
52-wk low
€46.88
No. of employees
11K
Open
€61.80
High
€61.80
Low
€61.80
Mkt. cap
28.01B
Avg. vol.
46.00
Volume
0.00
52-wk high
€77.17
52-wk low
€46.88
No. of employees
11K
News stories
From sources across the web
Profile
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S., and manufacturing facilities in Mesa, Arizona, U.S.; Batu Kawan, Malaysia; and Athenry, County Galway, Ireland. Wikipedia
About DexCom Inc
CEOKevin R. Sayer
Employees11K
Founded1999
HeadquartersSan Diego, California, United States
SectorMedical device
Websitedexcom.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.16B
1.21B
1.26B
1.19B
Cost of goods sold
468.30M
477.90M
466.90M
441.60M
Cost of revenue
468.30M
477.90M
466.90M
441.60M
Research and development expenses
148.20M
157.50M
148.20M
145.30M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
328.00M
331.40M
321.50M
349.70M
Operating expense
476.20M
488.90M
469.70M
495.00M
Total operating expenses
944.50M
966.80M
936.60M
936.60M
Operating income
212.60M
242.50M
323.00M
255.30M
Other non operating income
5.20M
81.80M
-1.60M
-2.20M
EBT including unusual items
241.10M
352.30M
340.70M
269.50M
EBT excluding unusual items
241.10M
352.30M
340.70M
269.50M
Income tax expense
61.30M
68.50M
73.40M
70.00M
Effective tax rate
25.43%
19.44%
21.54%
25.97%
Other operating expenses
-
-
-
-
Net income
179.80M
283.80M
267.30M
199.50M
Net profit margin
15.54%
23.47%
21.22%
16.74%
Earnings per share
0.48
0.61
0.68
0.56
Interest and investment income
28.00M
32.70M
23.50M
19.50M
Interest expense
-4.70M
-4.70M
-4.20M
-3.10M
Net interest expenses
23.30M
28.00M
19.30M
16.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
275.60M
306.10M
388.20M
322.40M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer